MW EG169 articl NS 20160223171404 captis executive search management consulting leadership board services

Chimerix initiated at outperform with $14 price target at Wedbush

MW EG169 articl NS 20160223171404 captis executive search management consulting leadership board services

Chimerix Inc.

Chimerix, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of pharmaceutical products. Its portfolio includes Brincidofovir for the treatment of adenovirus, cytomegalovirus, and smallpox. The company was founded by George R. Painter, III and Timothy Wollaeger in April 2000 and is headquartered in Durham, NC.

This is not a CAPTIS article. Originally, it was published here.